错误折叠的α-synuclein与阿尔茨海默病蛋白质病变的同时发生
Erin M Jonaitis1,2,3, Karen MacLeod4, Jennifer Lamoureux4
1Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
概括
在脑脊液中检测到错误折叠的α-synuclein (syn) 聚合物,与阿尔茨海默病标志物和认知衰退同时发生. 这表明在痴呆症风险队列中,综合病理是常见的.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 痴呆症研究 痴呆症研究
背景情况:
- 多病因痴呆症需要体内共病理标志物.
- 错误折叠的α-synuclein (syn) 是一种关键蛋白质,与各种神经退行性疾病有关.
- 准确检测合成聚合物对于了解疾病机制至关重要.
研究的目的:
- 用种子放大试验 (synSAA) 测量脑脊液 (CSF) 中错误折叠的合成聚合物 (syn-seeds).
- 研究合成种子与已确定的阿尔茨海默病 (AD) 生物标志物之间的关系,包括酸化 (T) 和粉样β (A).
- 检查合成种子与认知状态和纵向认知衰退的关联.
主要方法:
- 在AD风险队列中的420名参与者的CSF样本使用synSAA.被分析.
- 将SynSAA结果与酸化 (T) 和粉样β (A) 的水平进行了比较.
- 用混合效应模型评估和建模了纵向认知表现.
主要成果:
- 合成阳性 (synSAA+) 与酸化阳性 (36%对20%,p=0.011) 有意义地相关.
- synSAA+个体的认知障碍患病率较高 (10%与0%的痴呆症相比,p=0.00050).
- 与synSAA-参与者相比,synSAA+参与者的认知表现在数字符号替换测试中下降约40%更快.
结论:
- 这些发现支持阿尔法-同核素共病理在阿尔茨海默病风险队列中的存在,其中许多人没有认知障碍.
- 同核素阳性与阿尔茨海默病生物标志物和认知障碍有关.
- 需要进一步评估,以了解同核素和认知进展之间的关系,因为越来越多的参与者发展认知衰退.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.2K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
相关概念视频
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
